Application of Retinol to Human Skin In Vivo Induces Epidermal Hyperplasia and Cellular Retinoid Binding Proteins Characteristic of Retinoic Acid but Without Measurable Retinoic Acid Levels or Irritation
- 1 October 1995
- journal article
- clinical trial
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 105 (4) , 549-556
- https://doi.org/10.1111/1523-1747.ep12323445
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Topical glucocorticosteroids modulate the expression of CRABP I and II in human skin differentlyExperimental Dermatology, 1994
- Comparison of CD271 (Adapalene) and All-Trans Retinoic Acid in Human Skin: Dissociation of Epidermal Effects and CRABP-II mRNA ExpressionJournal of Investigative Dermatology, 1993
- Efficacy and safety of CD 271 alcoholic gels in the topical treatment of acne vulgarisBritish Journal of Dermatology, 1991
- Detection of messenger RNA using a digoxigenin end labelled oligodeoxynucleotide probe.Journal of Clinical Pathology, 1990
- Ligand‐specific and non‐specific in vivo modulation of human epidermal cellular retinoic acid binding protein (CRABP)European Journal of Clinical Investigation, 1989
- Identification of a second human retinoic acid receptorNature, 1988
- A human retinoic acid receptor which belongs to the family of nuclear receptorsNature, 1987
- 2: Final Report on the Safety Assessment of Retinyl Palmitate and RetinolJournal of the American College of Toxicology, 1987
- Rational therapy for acne vulgaris: An update on topical treatmentJournal of the American Academy of Dermatology, 1986
- The induction of differentiation in teratocarcinoma stem cells by retinoic acidCell, 1978